𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Assessment of Crohn's disease activity and α1-antitrypsin in faeces

✍ Scribed by Arndt, B.; Schürmann, G.; Betzler, M.; Herfarth, CH.; Schmidt-Gayk, H.


Book ID
122685247
Publisher
The Lancet
Year
1992
Tongue
English
Weight
184 KB
Volume
340
Category
Article
ISSN
0140-6736

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Fecal α1-antitrypsin (α1-AT): A marker o
✍ D. Herzog; E. Seidman; E. Delvin 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 133 KB

In a cohort study, the blood lipids of 35 children aged 6-8, 20 boys and 15 girls, and their parents were estimated to assess their relationship to energy expenditure measured using a minute-by-minute heart-rate method. Blood cholesterol and triglycerides were estimated using a Reflolron (Boehringer

Fecal α1-antitrypsin: A marker of intest
✍ D. Herzog; E. Delvin; Dr. E. Seidman 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 640 KB

Growth failure and malnutrition are major concerns in pediatric patients with frequent relapses of Crohn's disease (CD). In search of an early, noninvasive marker of relapse, we prospectively examined the relationship between levels of fecal al-antitrypsin (ctl-AT) in comparison with other known inf

Factors predicting the outcome of diseas
✍ Henrik Stjernman; Curt Tysk; Sven Almer; Magnus Ström; Henrik Hjortswang 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 174 KB 👁 1 views

Background: The Crohn's Disease Activity Index (CDAI) has become the gold standard for assessment of disease activity in CD. This study investigated the relationship between CDAI and the physicians' global assessment of disease activity (PGA) and whether different demographic and disease-related fac